Takehiko Kawanishi

A first-in-human phase 1 study of ACE910, a novel factor VIII–mimetic bispecific antibody, in healthy subjects

Naoki Uchida, Takehiko Sambe, Koichiro Yoneyama et al. · Blood · 2015 · 254 citations · Full text

Pharmacy, Hematology, Immunology +14

A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A

Koichiro Yoneyama, Christophe Schmitt, Naoki Kotani et al. · Clinical Pharmacokinetics · 2017 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Synthetic Studies of Vitamin D Analogues. XI. Synthesis and Differentiation-Inducing Activity of 1.ALPHA.,25-Dihydroxy-22-oxavitamin D3 Analogues.

Noboru Kubodera, Hiroyoshi Watanabe, Takehiko Kawanishi et al. · Chemical and Pharmaceutical Bulletin · 1992 · 41 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

High-performance liquid chromatography of inorganic anions using Fe3+ as a detection reagent

Toshio Imanari, Shinzo Tanabe, Toshihiko Toida et al. · Journal of Chromatography A · 1982 · 37 citations

Natural Sciences, Chemical Engineering, Chemistry +15

Relative and Absolute Bioavailability Study of Emicizumab to Bridge Drug Products and Subcutaneous Injection Sites in Healthy Volunteers

Naoki Kotani, Koichiro Yoneyama, Nobuhiko Kawakami et al. · Clinical Pharmacology in Drug Development · 2018 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16